PMDA drug package insert
アゾルガ配合懸濁性点眼液
PMDA Prescription drug · ノバルティスファーマ株式会社 · package insert Jul 1, 2021
Key facts
| Brand names | アゾルガ配合懸濁性点眼液 |
|---|---|
| Nonproprietary names | ブリンゾラミド・チモロールマレイン酸塩 |
| Companies | 製造販売（輸入）／ノバルティスファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 炭酸脱水酵素阻害剤/β遮断薬配合 緑内障・高眼圧症治療剤 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319821Q1027 |
| Approval numbers | 22500AMX01809000 |
| Package insert edition | 第1版 |
| Package insert date | Jul 1, 2021 |
| PMDA document key | 300242_1319821Q1027_2 |
| PMDA company code | 300242 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: